View Older Stories View More Recent Stories

Feb 21, 2024 07:03AM Emergent BioSolutions (EBS) Appoints Industry Leader Joseph C. Papa as New President and CEO
Feb 21, 2024 07:00AM Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
Nov 15, 2023 06:59AM Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
Nov 1, 2023 06:58AM Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance
Oct 26, 2023 06:59AM Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting
Oct 16, 2023 12:00PM Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1
Oct 4, 2023 06:59AM Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting
Sep 29, 2023 10:00AM Bausch + Lomb Completes Acquisition of XIIDRA®
Sep 26, 2023 06:59AM Bausch + Lomb Corporation (BLCO) Launches LUMIFY EYE ILLUMINATIONS in the US
Sep 26, 2023 06:59AM Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United States
Sep 20, 2023 06:59AM Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners
Sep 12, 2023 06:59AM Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States
Sep 6, 2023 05:58PM Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®
Sep 6, 2023 06:59AM Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting
Aug 29, 2023 07:00AM Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference
Aug 24, 2023 07:01AM Bausch + Lomb Corporation (BLCO) Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA
Aug 24, 2023 07:00AM Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA®
Aug 2, 2023 06:59AM Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook
Aug 1, 2023 08:04AM Bausch + Lomb Corporation (BLCO) Announces Leadership Changes
Aug 1, 2023 08:00AM Bausch + Lomb Solidifies Leadership Team
Jul 11, 2023 07:00AM Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2
Jul 6, 2023 07:03AM Bausch + Lomb Corporation (BLCO) Acquires Blink Eye Drops
Jul 6, 2023 07:00AM Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops
Jun 30, 2023 08:00AM Bausch + Lomb Corporation (BLCO) Acquires XIIDRA
Jun 30, 2023 08:00AM Bausch + Lomb Will Acquire XIIDRA®
Jun 12, 2023 07:00AM Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States
Jun 8, 2023 07:00AM Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceutical Products Will Be Presented During American Optometric Association's Optometry's Meeting
Jun 6, 2023 07:00AM Bausch + Lomb Launches Biotrue® Hydration Boost Contact Lens Rehydrating Drops in the United States
Jun 5, 2023 07:00AM Bausch + Lomb Launches Bausch + Lomb INFUSE® Multifocal Silicone Hydrogel Contact Lenses in the United States
Jun 1, 2023 07:01AM Bausch + Lomb Corporation (BLCO) Announces Key Leadership Changes
Jun 1, 2023 07:00AM Bausch + Lomb Announces Key Leadership Changes
May 18, 2023 01:56PM Bausch + Lomb (BLCO) and Novaliq Announce FDA Approval of MIEBO for Treatment of Signs and Symptoms of Dry Eye Disease
May 18, 2023 01:56PM Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease
May 3, 2023 06:59AM Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance
May 1, 2023 07:00AM Bausch + Lomb Releases Annual Environmental, Social and Governance Report
Apr 26, 2023 07:00AM Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting
Apr 25, 2023 07:00AM Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results
Apr 24, 2023 07:00AM Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System
Apr 20, 2023 07:00AM Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting
Apr 18, 2023 07:00AM Bausch + Lomb Reports More Than 65 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs
Apr 17, 2023 07:00AM Bausch + Lomb Will Release First-Quarter 2023 Financial Results on May 3
Apr 13, 2023 07:01AM Bausch + Lomb Corporation (BLCO) and Heidelberg Engineering Introduce SeeLuma Fully Digital Surgical Visualization Platform
Apr 13, 2023 07:00AM Bausch + Lomb and Heidelberg Engineering Announce the Introduction of SeeLuma™ Fully Digital Surgical Visualization Platform
Apr 12, 2023 07:00AM Bausch + Lomb Appoints Bob Bailey as Executive Vice President and Chief Legal Officer and Andrew Stewart as President, Ophthalmic Pharmaceuticals
Mar 22, 2023 07:00AM Bausch + Lomb Corporation (BLCO) and Novaliq Report Publication of Second Pivotal Phase 3 Data on NOV03
Mar 22, 2023 07:00AM Bausch + Lomb and Novaliq Announce Publication of Second Pivotal Phase 3 Data on NOV03 (Perfluorohexyloctane) in American Journal of Ophthalmology
Feb 22, 2023 06:59AM Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results
Feb 15, 2023 06:59AM Bausch + Lomb Corporation (BLCO) Appoints Brent Saunders as CEO and Board Chair
Feb 15, 2023 06:58AM Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023
Feb 14, 2023 04:41PM Carl Icahn trims Cheniere Energy (LNG) in Q4 - 13F
View More Recent Stories View Older Stories